0001217234-24-000035.txt : 20240409
0001217234-24-000035.hdr.sgml : 20240409
20240409174209
ACCESSION NUMBER: 0001217234-24-000035
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240409
DATE AS OF CHANGE: 20240409
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Johnson Alexander L
CENTRAL INDEX KEY: 0001617150
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36536
FILM NUMBER: 24833697
MAIL ADDRESS:
STREET 1: C/O DIADEXUS, INC.
STREET 2: 349 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CareDx, Inc.
CENTRAL INDEX KEY: 0001217234
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 943316839
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 MARINA BLVD
STREET 2: 4TH FLOOR
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 415-287-2300
MAIL ADDRESS:
STREET 1: 8000 MARINA BLVD
STREET 2: 4TH FLOOR
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: XDx, Inc.
DATE OF NAME CHANGE: 20071010
FORMER COMPANY:
FORMER CONFORMED NAME: EXPRESSION DIAGNOSTICS INC
DATE OF NAME CHANGE: 20030203
4/A
1
wk-form4a_1712698919.xml
FORM 4/A
X0508
4/A
2024-02-01
2024-02-05
0
0001217234
CareDx, Inc.
CDNA
0001617150
Johnson Alexander L
C/O CAREDX, INC.
8000 MARINA BOULEVARD
BRISBANE
CA
94005
0
1
0
0
See Remarks
0
Common Stock
2024-02-01
4
A
0
174520
0
A
345533
D
This amendment is being filed to report the grant of restricted stock units which was inadvertently omitted from the original Form 4 filed on February 5, 2024. This resulted in an additional 174,520 shares deemed beneficially owned by the Reporting Person which were inadvertently omitted from the original Form 4 and were also omitted from one Form 4 filed by the Reporting Person on February 6, 2024, which Form 4 should therefore have reflected a total of 344,413 shares deemed beneficially owned in Table I, Column 5.
The reported securities are represented by restricted stock units, 1/12th of which shall vest on May 1, 2024 and 1/12th of which shall vest on each date that is three months thereafter.
President of Patient and Testing Services
/s/ Alexander L. Johnson
2024-04-09